We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 4391I
GlaxoSmithKline PLC
30 August 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ======================================================================== a) Name Mr N Hirons === ======================== ============================================== b) Position/status SVP, Global Ethics & Compliance === ======================== ============================================== c) Initial notification/ Initial notification amendment === ======================== ============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================== a) Description of Ordinary shares of 25 pence each the financial ISIN: GB0009252882 instrument === ======================== ============================================== b) Nature of the Following the vesting on 26 August 2016 transaction of an award made on 24 September 2014 under the GlaxoSmithKline Deferred Investment Award Plan, Mr N Hirons will receive a cash payment of GBP288,000.11 less applicable tax withholding in respect of 17,489 notional ordinary shares. === ======================== ============================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------- GBP16.4675 17,489 notional ordinary shares. ----------- ------------------------- === ======================== ============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================== e) Date of the transaction 2016-08-26 === ======================== ============================================== f) Place of the n/a transaction === ======================== ==============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFBLFXQVFXBBZ
(END) Dow Jones Newswires
August 30, 2016 07:36 ET (11:36 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions